In summary, RICTOR inhibition impairs secretion of hypoxia-induced VEGF-A secretion and constitutive IL-8 secretion from pancreatic cancer cell lines which potentially affects the surrounding tumor stroma. Here, VEGFA is linked to neoplasm.